Trial Profile
Remifentanil and Hyperalgesia: Gradual Withdrawal Versus Immediate Discontinuation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Remifentanil (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 16 Oct 2017 Status changed from recruiting to completed.
- 15 Jul 2017 Planned End Date changed from 30 Jun 2017 to 30 Aug 2017.
- 15 Jul 2017 Planned primary completion date changed from 30 Jun 2017 to 30 Aug 2017.